BIOCON short-term swing -a good opportunity
BUY 330-332
Stoploss - 324
Target - 345, 350, 360
Comment:
FDA Bad news came for BIOCON on 22 July 2022 itself, so my idea became invalid.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
